Roflumilast Cream Safe, Effective for Kids With Psoriasis
"Limited topical treatments are approved for children younger than 12 years old with psoriasis."
Stay updated with breaking news from Worst Itch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Limited topical treatments are approved for children younger than 12 years old with psoriasis."
Phase 2 results show a reduction in itch in patients with notalgia paresthetica, but 19% of patients discontinued the trial because of side effects compared with 6% in the placebo group.
26.09.2022 - Study met both co-primary endpoints and all secondary endpointsAt week eight, 67.3% of individuals treated with roflumilast foam achieved Scalp-Investigator Global Assessment (S-IGA) Success compared to 28.1% of individuals treated with vehicleAt ... Seite 1
/PRNewswire/ -- AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on inflammatory conditions, has announced the...